Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens. (Q54329982)
Jump to navigation
Jump to search
scientific article published on 20 November 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens. |
scientific article published on 20 November 2013 |
Statements
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens (English)
Heath B Mackley
Kevin Staveley-O'Carroll
Christina Leah B Kline
Angelique Schiccitano
Junjia Zhu
Cheryl Beachler
Hassan Sheikh
Harold A Harvey
Kevin McKenna
Lisa Poritz
Evangelos Messaris
David Stewart